Abbott Laboratories’s recent filing unveils that its CHAIRMAN AND CEO Ford Robert B unloaded Company’s shares for reported $37.44 million on Feb 05 ’25. In the deal valued at $131.17 per share,285,388 shares were sold. As a result of this transaction, Ford Robert B now holds 220,059 shares worth roughly $28.9 million.
Then, Robert B. Ford bought 285,388 shares, generating $37,435,238 in total proceeds.
Before that, ALLEN HUBERT L sold 131,360 shares. Abbott Laboratories shares valued at $16,859,675 were divested by the EXECUTIVE VICE PRESIDENT at a price of $128.35 per share. As a result of the transaction, ALLEN HUBERT L now holds 184,806 shares, worth roughly $24.27 million.
Oppenheimer initiated its Abbott Laboratories [ABT] rating to an Outperform in a research note published on October 08, 2024; the price target was $130. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in mid September with a ‘”an Overweight”‘ rating. Edward Jones also remained covering ABT and has decreased its forecast on July 30, 2024 with a “Hold” recommendation from previously “Buy” rating. Goldman started covering the stock on May 30, 2024. It rated ABT as “a Buy”.
Price Performance Review of ABT
On Monday, Abbott Laboratories [NYSE:ABT] saw its stock jump 1.74% to $131.31. Over the last five days, the stock has gained 2.23%. Abbott Laboratories shares have risen nearly 16.09% since the year began. Nevertheless, the stocks have risen 15.89% over the past one year. While a 52-week high of $132.50 was reached on 02/05/25, a 52-week low of $99.71 was recorded on 01/15/25. SMA at 50 days reached $118.10, while 200 days put it at $111.90.
Levels Of Support And Resistance For ABT Stock
The 24-hour chart illustrates a support level at 129.46, which if violated will result in even more drops to 127.62. On the upside, there is a resistance level at 132.29. A further resistance level may holdings at 133.28. The Relative Strength Index (RSI) on the 14-day chart is 68.94, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.99, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 6.26%. Stochastics %K at 84.43% indicates the stock is a selling.
How much short interest is there in Abbott Laboratories?
A steep rise in short interest was recorded in Abbott Laboratories stocks on 2024-12-31, growing by 0.75 million shares to a total of 14.32 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 13.57 million shares. There was a rise of 5.23%, which implies that there is a positive sentiment for the stock.
